Multiple randomized controlled trials show that fecal microbiota transplantation is 44%–96%
effective in resolving recurrent C. difficile infection in patients with two or more recurrences. 1 …

Recurrent Clostridium difficile infection has been a major challenge for patients and
clinicians. Recurrence of infection after treatment with standard antibiotics is becoming more …

In recent years, Clostridium difficile infections have become more frequent, more severe,
more refractory to standard treatment, and more likely to recur. Current antibiotic treatment …

(CDI), then replacement of the microbiota with a more robust and diverse microbiota is a
logical means to restore colonization resistance against C. difficile [1]. What better …

Fecal microbiota transplantation (FMT) refers to instillation of processed stool bacteria
collected from a healthy donor into the intestinal tract of a patient with Clostridioides difficile …

Background Fecal microbiota transplant (FMT) appears safe and effective for treatment of
recurrent Clostridium difficile infection (RCDI). However, durability, long-term clinical …

OBJECTIVES: Clostridium difficileinfection (CDI) has increased to epidemic proportions over
the past 15 years, and recurrence rates of 30–65% with failure to respond to multiple …

In 2011, nearly half a million patients in the United States had a symptomatic Clostridium
difficile infection, and 29,000 died within 30 days after diagnosis. 1 The clinical spectrum of …

Clostridium difficile infection, a common hospital-associated infection, is a gastrointestinal
illness that becomes recurrent in about 25% of infected patients. Fecal microbiota …

Background and Aim Fecal microbiota transplantation (FMT) has been proposed as a
treatment option for patients with recurrent Clostridium difficile (C. difficile) infection but …